Table 2.
Variable | Outcome | Female | Male | Total | Sig. |
---|---|---|---|---|---|
Chronic Illness | Blood Disease | 0 (0%) | 2 (0.8%) | 2 (0.3%) | 0.107 * |
Cancer | 3 (0.6%) | 2 (0.8%) | 5 (0.6%) | 0.664 * | |
Chronic Hypertension | 16 (3.1%) | 18 (7.1%) | 34 (4.4%) | 0.010 | |
Other Cardiovascular Disease | 15 (2.9%) | 6 (2.4%) | 21 (2.7%) | 0.680 | |
Dermatologic Disease | 2 (0.4%) | 0 (0%) | 2 (0.3%) | 1.000 * | |
Diabetes Mellitus | 6 (1.1%) | 5 (2%) | 11 (1.4%) | 0.353 * | |
Other Endocrine Disorders | 26 (5%) | 4 (1.6%) | 30 (3.9%) | 0.021 | |
Gastrointestinal Disorders | 7 (1.3%) | 3 (1.2%) | 10 (1.3%) | 1.000 * | |
Liver Disease | 0 (0%) | 2 (0.8%) | 2 (0.3%) | 0.107 * | |
Obstructive Pulmonary Diseases | 15 (2.9%) | 1 (0.4%) | 16 (2.1%) | 0.023 | |
Ophthalmologic Disease | 1 (0.2%) | 0 (0%) | 1 (0.1%) | 1.000 * | |
Psychologic Distress | 0 (0%) | 2 (0.8%) | 2 (0.3%) | 0.107 * | |
Neurologic Disease | 4 (0.8%) | 4 (1.6%) | 8 (1%) | 0.449 * | |
Rheumatic Disorders | 6 (1.1%) | 1 (0.4%) | 7 (0.9%) | 0.437 * | |
Total | 88 (16.8%) | 42 (16.5%) | 130 (16.7%) | 0.910 | |
Medical Treatment | Antiarrhythmic | 8 (1.5%) | 3 (1.2%) | 11 (1.4%) | 1.000 * |
Anti-asthmatic | 5 (1%) | 0 (0%) | 5 (0.6%) | 0.179 * | |
Antibiotics | 1 (0.2%) | 1 (0.4%) | 2 (0.3%) | 0.548 * | |
Anticoagulants | 8 (1.5%) | 7 (2.7%) | 15 (1.9%) | 0.271 * | |
Antidepressants | 34 (6.5%) | 7 (2.7%) | 41 (5.3%) | 0.028 | |
Antidiabetics | 6 (1.1%) | 8 (3.1%) | 14 (1.8%) | 0.080 * | |
Antiepileptics | 1 (0.2%) | 4 (1.6%) | 5 (0.6%) | 0.042 * | |
Antihistamines | 9 (1.7%) | 0 (0%) | 9 (1.2%) | 0.035 * | |
Antihypertensive | 16 (3.1%) | 17 (6.7%) | 33 (4.2%) | 0.019 | |
Cholesterol Medications | 2 (0.4%) | 6 (2.4%) | 8 (1%) | 0.017 * | |
Oral Contraceptives | 4 (0.8%) | - | - | - | |
Gastrointestinal Medications | 4 (0.8%) | 3 (1.2%) | 7 (0.9%) | 0.689 * | |
Immunosuppressives | 6 (1.1%) | 3 (1.2%) | 9 (1.2%) | 1.000 * | |
Thyroid Hormone Supplement | 35 (6.7%) | 2 (0.8%) | 37 (4.7%) | <0.001 | |
Other Drugs | 14 (2.7%) | 4 (1.6%) | 18 (2.3%) | 0.336 | |
Total | 134 (25.6%) | 47 (18.4%) | 181 (23.2%) | 0.027 |
Chi-squared test and Fisher’s exact test (*) were used with a significance level (Sig.) of ≤0.05.